Ocugen (OCGN) Other Operating Expenses (2014 - 2020)

Ocugen (OCGN) posted Other Operating Expenses of $7.0 million for Q3 2020, up 350.99% on a QoQ basis from -$2.8 million in Q1 2019.

Ocugen (OCGN) Other Operating Expenses (2014 - 2020) Analysis & Trends

Ocugen's Other Operating Expenses history runs 5 years deep, the most recent figure standing at $7.0 million for Q3 2020.

  • Quarterly Other Operating Expenses changed N/A year-over-year to $7.0 million in Q3 2020, while the trailing twelve-month figure through Jun 2021 was $7.0 million (changed N/A YoY) and the FY2020 annual result came in at $7.0 million, changed N/A from the prior year.
  • Other Operating Expenses was $7.0 million for Q3 2020 at Ocugen, up from -$2.8 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $7.0 million in Q3 2020 and bottomed at -$2.8 million in Q1 2019.
  • A 3-year average of $1.5 million and a median of $200000.0 in 2016 frame the typical range for Other Operating Expenses.
  • Peak annual rise in Other Operating Expenses reached 35.48% in 2016, while the deepest fall reached 35.48% in 2016.
  • Ocugen's Other Operating Expenses stood at $200000.0 in 2016, then tumbled by 1494.5% to -$2.8 million in 2019, then soared by 350.99% to $7.0 million in 2020.
  • Business Quant data shows OCGN's Other Operating Expenses at $7.0 million in Q3 2020, -$2.8 million in Q1 2019, and $200000.0 in Q4 2016.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Ocugen 399.60 Mn 399.60 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2020 7.00 Mn
Mar 31, 2019 -2.79 Mn
Dec 31, 2016 200,000.00
Dec 31, 2015 310,000.00
Dec 31, 2014 60,000.00